Shandong Longlive Bio-Technology Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 310.777 million compared to CNY 675.506 million a year ago. Operating loss was CNY 324.017 million compared to CNY 255.590 million a year ago. Net loss was CNY 321.165 million compared to CNY 253.474 million a year ago. Basic loss per share from continuing operations was CNY 0.54 compared to CNY 0.42 a year ago.